这是一篇来自已证抗体库的有关人类 CD22的综述,是根据22篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD22 抗体。
CD22 同义词: SIGLEC-2; SIGLEC2; B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; sialic acid-binding Ig-like lectin 2

BioLegend
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD22抗体(Biolegend, 302502)被用于被用于流式细胞仪在人类样品上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类; 图 s4b
BioLegend CD22抗体(Biolegend, 302514)被用于被用于流式细胞仪在人类样品上 (图 s4b). J Clin Invest (2018) ncbi
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类
BioLegend CD22抗体(Biolegend, HIB22)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2014) ncbi
赛默飞世尔
小鼠 单克隆(RFB-4)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD22抗体(Invitrogen, RFB4)被用于被用于流式细胞仪在人类样品上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(RFB-4)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD22抗体(Caltag, RFB4)被用于被用于流式细胞仪在人类样品上 (表 1). Haematologica (2004) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(RFB4)
  • 流式细胞仪; 狗
艾博抗(上海)贸易有限公司 CD22抗体(Abcam, Ab23620)被用于被用于流式细胞仪在狗样品上. F1000Res (2015) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(SJ10.1H11)
  • 流式细胞仪; 人类; 表 3
贝克曼库尔特实验系统(苏州)有限公司 CD22抗体(Beckman Coulter, SJ10.1H11)被用于被用于流式细胞仪在人类样品上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(SJ10.1H11)
  • 流式细胞仪; 人类; 图 1e
贝克曼库尔特实验系统(苏州)有限公司 CD22抗体(Beckman Coulter, SJ10)被用于被用于流式细胞仪在人类样品上 (图 1e). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(SJ10.1H11)
  • 流式细胞仪; 人类; 表 4
贝克曼库尔特实验系统(苏州)有限公司 CD22抗体(Beckman Coulter, SJ10.1H11)被用于被用于流式细胞仪在人类样品上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(SJ10.1H11)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD22抗体(Beckman Coulter, IM3704)被用于被用于流式细胞仪在人类样品上. Contemp Oncol (Pozn) (2014) ncbi
碧迪BD
小鼠 单克隆(S-HCL-1)
  • 流式细胞仪; 人类; 图 st12
碧迪BD CD22抗体(BD, S-HCL-1)被用于被用于流式细胞仪在人类样品上 (图 st12). Science (2017) ncbi
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类; 图 4b
碧迪BD CD22抗体(BD, HIB22)被用于被用于流式细胞仪在人类样品上 (图 4b). Front Immunol (2017) ncbi
小鼠 单克隆(S-HCL-1)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD22抗体(BD Biosciences, 347577)被用于被用于流式细胞仪在人类样品上 (图 st1). PLoS ONE (2016) ncbi
小鼠 单克隆(S-HCL-1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD22抗体(BD Biosciences, 347577)被用于被用于流式细胞仪在人类样品上 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(HIB22)
  • 其他; 人类; 500 ug/ml; 图 2
碧迪BD CD22抗体(Becton Dickinson, 555423)被用于被用于其他在人类样品上浓度为500 ug/ml (图 2). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD22抗体(BD Biosciences, HIB22)被用于被用于流式细胞仪在人类样品上 (图 2a). J Immunol (2016) ncbi
小鼠 单克隆(S-HCL-1)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD22抗体(BD, 347577)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(S-HCL-1)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD22抗体(BD Biosciences, S-HCL-1)被用于被用于其他在人类样品上 (图 st1) 和 被用于流式细胞仪在人类样品上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(HIB22)
  • 流式细胞仪; 人类
碧迪BD CD22抗体(BD, HIB22)被用于被用于流式细胞仪在人类样品上. Nature (2015) ncbi
小鼠 单克隆(S-HCL-1)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD22抗体(Becton Dickinson, S-HCL-1)被用于被用于流式细胞仪在人类样品上 (图 2c). Clin Immunol (2014) ncbi
西格玛奥德里奇
小鼠 单克隆(HIB22)
  • 免疫细胞化学; 人类; 1 ug/ml
西格玛奥德里奇 CD22抗体(Sigma, HIB22)被用于被用于免疫细胞化学在人类样品上浓度为1 ug/ml. Traffic (2014) ncbi
默克密理博中国
小鼠 单克隆(RFB4)
  • 免疫组化; 人类
默克密理博中国 CD22抗体(Millipore, RFB4)被用于被用于免疫组化在人类样品上. Arthritis Rheumatol (2014) ncbi
文章列表
  1. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  2. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  3. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  4. Ito D, Childress M, Mason N, Winter A, O BRIEN T, Henson M, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res. 2015;4:42 pubmed 出版商
  5. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed 出版商
  6. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  7. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed 出版商
  8. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed 出版商
  9. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  10. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  11. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  12. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  13. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed 出版商
  14. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  15. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed 出版商
  16. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  17. Jovanovic D, Djurdjevic P, Andjelkovic N, Zivić L. Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia. Contemp Oncol (Pozn). 2014;18:29-33 pubmed 出版商
  18. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed 出版商
  19. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed 出版商
  20. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  21. Ingle G, Scales S. DropArray™, a wall-less 96-well plate for uptake and immunofluorescence microscopy, confirms CD22 recycles. Traffic. 2014;15:255-72 pubmed 出版商
  22. del Giudice I, Matutes E, Morilla R, Morilla A, Owusu Ankomah K, Rafiq F, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303-8 pubmed